- Filed
- Aug 22, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jul 31, 2025 | 270.18M sh |
| Shares Diluted | Q2 2025 · Jul 31, 2025 | 270.24M sh |
| Shares Diluted | Q2 2025 · Jul 31, 2024 | 267.95M sh |
| Shares Diluted | Q2 2025 · Jul 31, 2024 | 269.13M sh |
| Stock Repurchased | Q2 2025 · Jul 31, 2025 | $589M |
| Stock Repurchased | Q2 2025 · Jul 31, 2024 | $440M |
| Capex | Q2 2025 · Jul 31, 2025 | $64M |
| Capex | Q2 2025 · Jul 31, 2024 | $136M |
| Operating Cash Flow | Q2 2025 · Jul 31, 2025 | $1.07B |
| Operating Cash Flow | Q2 2025 · Jul 31, 2024 | $943M |
| Long Term Debt | Q2 2025 · Jul 31, 2025 | $2.99B |
| Long Term Debt | Q2 2025 · Jan 31, 2025 | $2.98B |
| Cash And Equivalents | Q2 2025 · Jul 31, 2025 | $1.26B |
| Cash And Equivalents | Q2 2025 · Jan 31, 2025 | $1.54B |
| Cash And Equivalents | Q2 2025 · Jul 31, 2024 | $1.64B |
| Stockholders Equity | Q2 2025 · Jul 31, 2025 | $9.17B |
| Stockholders Equity | Q2 2025 · Jan 31, 2025 | $9.03B |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | $8.35B |
| Current Liabilities | Q2 2025 · Jul 31, 2025 | $4.95B |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $5.55B |
| Total Liabilities | Q2 2025 · Jul 31, 2025 | $8.79B |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $8.94B |
| Current Assets | Q2 2025 · Jul 31, 2025 | $10.41B |
| Current Assets | Q2 2025 · Jan 31, 2025 | $10.55B |
| Total Assets | Q2 2025 · Jul 31, 2025 | $17.96B |
| Total Assets | Q2 2025 · Jan 31, 2025 | $17.98B |
| Eps Diluted | Q2 2025 · Jul 31, 2025 | $0.84 |
| Eps Diluted | Q2 2025 · Jul 31, 2025 | $1.09 |
| Eps Diluted | Q2 2025 · Jul 31, 2024 | $0.49 |
| Eps Diluted | Q2 2025 · Jul 31, 2024 | $0.89 |
| Eps Basic | Q2 2025 · Jul 31, 2025 | $0.86 |
| Eps Basic | Q2 2025 · Jul 31, 2025 | $1.11 |
| Eps Basic | Q2 2025 · Jul 31, 2024 | $0.50 |
| Eps Basic | Q2 2025 · Jul 31, 2024 | $0.90 |
| Sga Expense | Q2 2025 · Jul 31, 2025 | $216M |
| Sga Expense | Q2 2025 · Jul 31, 2025 | $429M |
| Sga Expense restated | Q2 2025 · Jul 31, 2024 | $202M |
| Sga Expense restated | Q2 2025 · Jul 31, 2024 | $403M |
| Rd Expense | Q2 2025 · Jul 31, 2025 | $660M |
| Rd Expense | Q2 2025 · Jul 31, 2025 | $1.32B |
| Rd Expense | Q2 2025 · Jul 31, 2024 | $649M |
| Rd Expense | Q2 2025 · Jul 31, 2024 | $1.31B |
| Net Income | Q2 2025 · Jul 31, 2025 | $228M |
| Net Income | Q2 2025 · Jul 31, 2025 | $296M |
| Net Income | Q2 2025 · Jul 31, 2024 | $132M |
| Net Income | Q2 2025 · Jul 31, 2024 | $239M |
| Operating Income | Q2 2025 · Jul 31, 2025 | $248M |
| Operating Income | Q2 2025 · Jul 31, 2025 | $287M |
| Operating Income | Q2 2025 · Jul 31, 2024 | $111M |
| Operating Income | Q2 2025 · Jul 31, 2024 | $175M |
| Revenue | Q2 2025 · Jul 31, 2025 | $2.35B |
| Revenue | Q2 2025 · Jul 31, 2025 | $4.59B |
| Revenue | Q2 2025 · Jul 31, 2024 | $2.09B |
| Revenue | Q2 2025 · Jul 31, 2024 | $4.08B |